Ethane

Ethane

SCHEMBL7579504

CC.O=C(O)c1cccc(I)c1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.55
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA6 P23280 1/20 0.54
CA9 Q16790 1/20 0.54
HSD17B10 Q99714 2/20 0.50
KMO O15229 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
UNG P13051 1/20 0.48
TPMT P51580 1/20 0.48
DAO P14920 1/20 0.48
TSHR P16473 1/20 0.48
NAPRT Q6XQN6 1/20 0.48
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29532021 0.96 CA12 (0.58) MTORCA12CA1CA2CA6
SCHEMBL40282 0.96 CA12 (0.58) MTORCA12CA1CA2CA6
Hydrochloric Acid SCHEMBL4455397 0.93 CA12 (0.56) MTORCA12CA1CA2CA6
Methane SCHEMBL14879758 0.93 CA12 (0.56) MTORCA12CA1CA2CA6
Acetaldehyde SCHEMBL9117054 0.90 UNG (0.53) MTORCA12CA1CA2CA6
Toluene SCHEMBL27999625 0.88 MTOR (0.50) MTORCA12CA1CA2CA6
Aziridine SCHEMBL3898809 0.86 CA12 (0.48) MTORCA12CA1CA2CA6
SCHEMBL7358622 0.85 KDM4E (0.57) MTORCA12CA1CA2CA6
SCHEMBL172793 0.80 ALDH1A1 (0.50) MTORKMT2AMEN1ALDH1A1TDP1
SCHEMBL3673834 0.79 ATM (0.58) MTORALDH1A1TDP1L3MBTL1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193578-A1 Compounds having activity as inhibitors of cytochrome P450RAI ALLERGAN, INC. 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193578-A1 Compounds having activity as inhibitors of cytochrome P450RAI RARA, RARB, RARG MTOR 4400/4885CA12 2693/4885CA1 2674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.